NEW YORK (GenomeWeb News) — GenOway will supply “a leading” but undisclosed US pharmaceutical company with its genetically modified mouse lines in exchange for up to $2 million, the firm said yesterday.
 
GenOway makes a line of genetically modified mouse and rat lines, and uses knowledge in transgenic technologies including pronuclear microinjection, knock-out, knock-in, knock-down, point mutation, in vivo drug screening, drug efficacy, and safety testing.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.